Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

N/AEnrolling By InvitationNCT07166588

Seoul National University Hospital2,000 enrolled

Overview

This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Crohn Disease (CD)Ulcerative Colitis (UC)IBD (Inflammatory Bowel Disease)

Eligibility

Sex: ALLMin age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring. Exclusion Criteria: * Patients diagnosed with cancer or with a history of cancer treatment. * Participation may be restricted at the discretion of the medical team. * Infants and young children under the age of 10.

Locations (1)

Outcomes

Primary Outcomes

Prediction model in the patients with inflammatory bowel disease for treatment response

Development of a prognostic prediction model for patients with inflammatory bowel disease and a predictive model for therapeutic response to biologic agents and small molecule therapies

Time frame: From enrollment to the end of treatment at 12 weeks